メリーランド州における肺がんの臨床試験
メリーランド州内の拠点で、肺がんに関する56件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Luminis Health Anne Arundel Medical Center, Annapolis
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- 他7件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848Evaluation for NCI Surgery Branch Clinical Research Protocols
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳以上 · 全性別 · 2026/10/02更新 · NCT00001823Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
2歳〜120歳 · 全性別 · 2026/10/02更新 · NCT00242723Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
2歳〜100歳 · 全性別 · 2026/10/02更新 · NCT01950572Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT06885697Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
- MedStar Franklin Square Medical Center ( Site 0033), Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06780098Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- 他10件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
3歳以上 · 全性別 · 2026/10/02更新 · NCT01441089A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster
被験者募集中第3相
70歳以上 · 全性別 · 2026/10/01更新 · NCT06096844Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- UM Upper Chesapeake Hematology and Oncology - Aberdeen, Aberdeen
- UPMC Western Maryland, Cumberland
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Johns Hopkins University of Medicine, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784DK222 Study at Hopkins
- Johns Hopkins Hospital, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07140315Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/28更新 · NCT00034216Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Maryland Oncology Hematology, P.A., Annapolis
- Maryland Oncology Hematology, P.A., Bethesda
- Maryland Oncology Hematology, P.A., Brandywine
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07154290Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Baltimore
被験者募集中第2相
18歳〜95歳 · 全性別 · 2026/09/23更新 · NCT05061550Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06712316Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Johns Hopkins, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07349537Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06287775A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Saint Agnes Hospital - Baltimore - Hunt - PPDS, Baltimore
- Walter Reed National Military Medical Center, Bethesda
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06793215A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Johns Hopkins Bayview Medical Center, Baltimore
- USO - Maryland Oncology Hematology, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06343402The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/01更新 · NCT06712355T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜72歳 · 全性別 · 2026/08/31更新 · NCT02133196A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- MedStar Franklin Square Medical Center ( Site 0033), Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06731907Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- TidalHealth Richard A Henson Cancer Institute, Ocean Pines
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05624996A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
- Johns Hopkins University, Baltimore
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/06更新 · NCT05995821Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
- University of Maryland Baltimore Washington Medical Center, Glen Burnie
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/29更新 · NCT07008664A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT05652686Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
- Maryland Oncology Hematology, Calverton
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07315113EXoPERT EMERALD Clinical Study
- John Hopkins University, Baltimore
被験者募集中観察研究健康なボランティア歓迎
45歳以上 · 全性別 · 2026/07/01更新 · NCT07186296Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699GCC 2546- Motion Management
- University of Maryland Greenebaum Cancer Center, Baltimore
被験者募集中
18歳以上 · 全性別 · 2026/06/26更新 · NCT07398209Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/06/05更新 · NCT00451022Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- UPMC Western Maryland, Cumberland
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Johns Hopkins University, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。